Skip to main content

Advertisement

SpringerLink
Log in

Non-standard PET radionuclides: time to get ready for new clinical PET strategies

  • Focus on ...
  • Published:
European Journal of Nuclear Medicine and Molecular Imaging Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. BIO-TECH Report #240, The Market for PET Radiopharmaceuticals & PET Imaging. http://www.biotechsystems.com/reports/240/default.asp.

  2. Pagani M, Stone-Elander S, Larsson SA. Alternative positron emission tomography with non-conventional positron emitters: effects of their physical properties on image quality and potential clinical applications. Eur J Nucl Med 1997;24(10):1301–27.

    Article  PubMed  CAS  Google Scholar 

  3. Sajjad M, Bars E, Nabi HA. Optimization of 124I production via 124Te(p,n)124I reaction. Appl Radiat Isot 2006;64(9):965–70.

    Article  PubMed  CAS  Google Scholar 

  4. Abbas K, Kozempel J, Bonardi M, Groppi F, Alfarano A, Holzwarth U, et al. Cyclotron production of 64Cu by deuteron irradiation of 64Zn. Appl Radiat Isot 2006;64(9):1001–5.

    Article  PubMed  CAS  Google Scholar 

  5. Fan X, Parker DJ, Smith MD, Ingram A, Yang Z, Seville JP. A simple and selective method for the separation of Cu radioisotopes from nickel. Nucl Med Biol 2006;33(7):939–44.

    Article  PubMed  CAS  Google Scholar 

  6. Bigott HM, Laforest R, Liu X, Ruangma A, Wuest F, Welch MJ. Advances in the production, processing and microPET image quality of technetium-94m. Nucl Med Biol 2006;33(7):923–33.

    Article  PubMed  CAS  Google Scholar 

  7. Clifford T, Boswell CA, Biddlecombe GB, Lewis JS, Brechbiel MW. Validation of a novel CHX-A″ derivative suitable for peptide conjugation: small animal PET/CT imaging using yttrium-86-CHX-A″-octreotide. J Med Chem 2006;49(14):4297–304.

    Article  PubMed  CAS  Google Scholar 

  8. Dingli D, Kemp BJ, O’Connor MK, Morris JC, Russell SJ, Lowe VJ. Combined I-124 positron emission tomography/computed tomography imaging of NIS gene expression in animal models of stably transfected and intravenously transfected tumor. Mol Imaging Biol 2006;8(1):16–23.

    Article  PubMed  Google Scholar 

  9. Pal A, Glekas A, Doubrovin M, Balatoni J, Beresten T, Maxwell D, et al. Molecular imaging of EGFR kinase activity in tumors with 124I-labeled small molecular tracer and positron emission tomography. Mol Imaging Biol 2006;8(5):262–77.

    Article  PubMed  CAS  Google Scholar 

  10. McBride WJ, Zanzonico P, Sharkey RM, Noren C, Karacay H, Rossi EA, et al. Bispecific antibody pretargeting PET (immunoPET) with an 124I-labeled hapten-peptide. J Nucl Med 2006;47(10):1678–88.

    PubMed  CAS  Google Scholar 

  11. Parry JJ, Andrews R, Rogers BE. MicroPET imaging of breast cancer using radiolabeled bombesin analogs targeting the gastrin-releasing peptide receptor. Breast Cancer Res Treat 2006; Jul 13; [Epub ahead of print].

  12. Peng F, Lu X, Janisse J, Muzik O, Shields AF. PET of human prostate cancer xenografts in mice with increased uptake of 64CuCl2. J Nucl Med 2006;47(10):1649–52.

    PubMed  CAS  Google Scholar 

  13. Yuan H, Schroeder T, Bowsher JE, Hedlund LW, Wong T, Dewhirst MW. Intertumoral differences in hypoxia selectivity of the PET imaging agent 64Cu(II)-diacetyl-bis(N4-methylthiosemicarbazone). J Nucl Med 2006;47(6):989–98.

    PubMed  CAS  Google Scholar 

  14. Dehdashti F, Grigsby RW, Mintun MA, Lewis JS, Siegel BA, Welch MJ. Assessing tumor hypoxia in cervical cancer by positron emission tomography with60Cu-ATSM: relationship to therapeutic response—a preliminary report. Int J Radiat Oncol Biol Phys 2003;55(5):1233–8.

    PubMed  Google Scholar 

  15. Dehdashti F, Mintun MA, Lewis JS, Bradley J, Govindan R, Laforest R, et al. In vivo assessment of tumor hypoxia in lung cancer with 60Cu-ATSM. Eur J Nucl Med Mol Imaging 2003;30:844–50.

    Article  PubMed  CAS  Google Scholar 

  16. Lubberink M, van Schie A, de Jong HW, van Dongen GA, Teule GJ. Acquisition settings for PET of 124I administered simultaneously with therapeutic amounts of 131I. J Nucl Med 2006;47(8):1375–81.

    PubMed  CAS  Google Scholar 

  17. Berding G, Schneider U, Gielow P, Buchert R, Donnerstag F, Brandau W, et al. Feasibility of central cannabinoid CB1 receptor imaging with [124I]AM281 PET demonstrated in a schizophrenic patient. Psychiatry Res 2006;147(2–3):249–56.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institute of Radiological Sciences, University of Milan, Unit of Nuclear Medicine, Hospital San Paolo, Via Antonio di Rudinì, 8, 20142, Milan, Italy

    Giovanni Lucignani

Authors
  1. Giovanni Lucignani
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Giovanni Lucignani.

Additional information

The commentaries in this section derive from a literature search and include summaries of articles compiled and linked to each other by extensive use of the text contained in the articles examined.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lucignani, G. Non-standard PET radionuclides: time to get ready for new clinical PET strategies. Eur J Nucl Med Mol Imaging 34, 294–300 (2007). https://doi.org/10.1007/s00259-006-0330-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00259-006-0330-0

Keywords

Search

Navigation